|
|
||||||||
Original Research Communication |
1 From the Jean Mayer US Department of Agriculture, Human Nutrition Research Center on Aging at Tufts University, Boston.
2 Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee by the US Department of Agriculture and does not imply approval to the exclusion of other products that may be suitable.
3 Supported by the Comunidad de Madrid (CS-M). 4 Address reprint requests to RL Prior, USDA-ARS, Arkansas Children's Nutrition Center, 1120 Marshall Street, Little Rock, AR 72202. E-mail: PriorRonaldL{at}uams.edu.
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective of this study was to determine whether anthocyanins can be absorbed as glycosides and to evaluate their pharmacokinetics in humans.
Design: Four healthy elderly women consumed 720 mg anthocyanins. A series of blood and urine samples were collected before and after consumption of the anthocyanins. Anthocyanins were measured in plasma and urine by combining an octadecylsilane solid-phase extraction for sample preparation and an HPLC system with diode array for anthocyanin separation and detection. The structures of anthocyanins as glycosides in plasma and urine were further confirmed by using liquid chromatographymass spectrometry.
Results: Anthocyanins were detected as glycosides in plasma and urine. The maximum plasma concentration of total anthocyanins varied from 55.3 to 168.3 nmol/L, with an average of 97.4 nmol/L, and was reached within 71.3 min. The elimination of plasma anthocyanins appeared to follow first-order kinetics. The elimination half-life of plasma total anthocyanins was calculated to be 132.6 min. Most anthocyanin compounds were excreted in urine during the first 4 h. The excretion rate of total anthocyanins was 77 µg/h during the first 4 h and 13 µg/h during the second 4 h.
Conclusion: Anthocyanins are absorbed in their unchanged glycated forms in elderly women.
Key Words: Anthocyanins flavonoids antioxidants pharmacokinetics absorption elderly women
| INTRODUCTION |
|---|
|
|
|---|
Natural anthocyanins are prescribed as medicines in many countries. They have been reported to have positive effects in the treatment of various microcirculation diseases resulting from capillary fragility (1316), such as preventing cholesterol-induced atherosclerosis (17), inhibiting platelet aggregation, and improving visual function (18, 19). There have been no reported adverse effects from ingestion of grape anthocyanins in humans since grape skin extracts were approved by the Food and Drug Administration to be used as a food colorant (20).
Anthocyanins are widely distributed in fruit and vegetables, such as blueberries, elderberries, strawberries, blackberries, cranberries, raspberries, cherries, currants, grapes, plums, red onions, red cabbage, sweet potatoes, and corn. Red wine is also rich in anthocyanins (21). The intake of anthocyanins in humans has been estimated to be 180215 mg/d in the United States (22), which is much higher than the intake (23 mg/d) of other flavonoids, including quercetin, kaempferol, myricetin, apigenin, and luteolin (23).
However, anthocyanins exist in plants as glycosides, which were long considered nonabsorbable in humans. Therefore, the pharmacokinetics of dietary anthocyanins are not known in humans. Recently, we developed an HPLC procedure for measuring the anthocyanins in plasma and showed clearly, for the first time in one human subject, that anthocyanins are absorbed in the blood (24). In the present study we investigated further whether anthocyanins are absorbed in their original glycated forms in 4 elderly women. The pharmacokinetics of these dietary components were also determined.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
4 wk before the start of the study; and 4) no smoking. The study protocol was approved by the Human Investigation Review Committee of Tufts University and the New England Medical Center and written, informed consent was obtained from each study participant.
Study design
Each subject was admitted to the Metabolic Research Unit (MRU) at the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University 48 h before the day of sampling. Subjects fasted overnight in the evening before the day of sampling. In the morning of the sampling day, an intravenous catheter was inserted into one forearm. A 15-mL heparin-treated blood sample (zero baseline sample) was obtained from each fasting subject, after which the subjects were given 720 mg anthocyanins contained in 12 g elderberry extract dissolved in 500 mL water before the study. The elderberry extract contained mainly cyanidin 3-sambubioside, cyanidin 3-glucoside, and maltodextrin. Blood samples (15 mL) were collected again at 10, 20, 30, and 45 min and 1, 2, 4, 6, and 24 h after consumption of the elderberry anthocyanins. Urine samples were collected from these subjects before the consumption of the elderberry anthocyanins and between 0 and 2, 2 and 4, 4 and 6, 6 and 8, 8 and 12, and 12 and 24 h after consumption of the elderberry anthocyanins.
Lunch was provided 4 h after the blood sampling and dinner was provided 11 h after consumption of the drink. The diets provided to these subjects during their residency in the MRU were designed to contain no anthocyanins, to be low in other flavonoids, and to meet the recommended dietary allowances for protein and energy (25). All meals were prepared under the supervision of a dietitian in the MRU. The consumption of water was not limited but food and other beverages were not allowed during the residency.
Anthocyanin analysis in plasma and urine
The blood samples were centrifuged at 500 x g for 10 min at 4°C. The plasma samples were quickly removed and immediately treated with an aqueous solution of 0.44 mol trifluoroacetic acid/L (1:0.2, by vol) as previously described (24). These trifluoroacetic acidtreated plasma samples were then stored at -80°C before HPLC and HPLCmass spectrometric analyses for anthocyanins. The urine samples were also treated with 0.44 mol trifluoroacetic acid/L (1:0.2, by vol) and then stored at -80°C before analyses for anthocyanins.
Malvidin 3-galactoside was added to the plasma samples (2 mL) to a final concentration of 1 µg/L. Malvidin 3-galactoside was not detected in the elderberry anthocyanins and was used as an internal standard to correct for the possible loss of anthocyanins during the sample preparation. The plasma sample was then extracted by using the octadecylsilane solid-phase extraction cartridge (Sep-Pak C18) as previously described (24). Water-soluble compounds, polar lipids, and neutral lipids in the plasma samples were eluted with an aqueous solution of 25 mmol sodium acetate/L (pH 1.5), dichloromethane, and benzene, respectively. Anthocyanins were recovered finally with methanol containing 25 mmol sodium acetate/L (pH 1.5) for HPLC analysis or with methanol containing 5% formic acid for analysis by liquid chromatographymass spectrometry (LC-MS). The anthocyanins in the methanol phase were evaporated to dryness, redissolved in the methanol containing 25 mmol sodium acetate/L, and mixed with an aqueous solution of 25 mmol sodium acetate/L (1:3, by vol). After being centrifuged to remove any possible undissolved materials, the sample was analyzed for anthocyanins by HPLC with an HP series 1100 including an autosampler, a binary pump, a Zorbax SB-C18 column (4.6 x 250 nm), and a diode array detector (Agilent Technologies, Palo Alto, CA). For LC-MS, the anthocyanins in the methanol phase were evaporated and redissolved in the methanol containing 5% formic acid. Low-resolution electrospray mass spectrometry was performed with an Esquire-LC Mass Spectrometer (Bruker Daltonik, Bremen, Germany), an ion trap instrument equipped with an electrospray interface. The mass spectrometer was operated in the positive-ion mode (electrospray voltage, 4000 V; capillary exit, 95.6 V; capillary offset, 69.8 V; skim 1, 25.8 V; dry gas, 9 L/min; temperature, 300°C).
The urine samples were also treated with the Sep-Pak C18 extraction cartridge; 10 mL urine was loaded on the cartridge and washed with an aqueous solution of 15 mL of 25 mmol sodium acetate/L (pH 1.5). Anthocyanins were then recovered with 2 mL methanol containing 25 mmol sodium acetate/L (pH 1.5) or 5% formic acid, which was directly used for HPLC or LC-MS after filtration. The recovery of anthocyanins in urine samples was >90%. Therefore, the internal standard was not routinely used for the analysis of anthocyanin in urine.
| RESULTS |
|---|
|
|
|---|
|
|
) of plasma total anthocyanins was calculated to be 132.6 min (Table 1
of plasma cyanidin 3-sambubioside were 38.9 nmol/L, 71.3 min, and 168.9 min, respectively. The Cmax, tmax, and t
of plasma cyanidin 3-glucoside were 42.5 nmol/L, 65.0 min, and 97.3 min, respectively (Table 1
|
|
6 peaks were detected at 520 nm in the urine samples collected after consumption of the elderberry anthocyanins (Figure 4
|
|
|
| DISCUSSION |
|---|
|
|
|---|
3 absorption peaks (at 280, 430, and 520 or 550 nm, respectively), with the main one at 430 nm. Anthocyanins should not have an absorption peak around 430 nm. Using LC-MS in this study, we showed clearly that anthocyanins were absorbed as glycosides in the elderly women. The longer t
of cyanidin 3-sambubioside than of cyanidin 3-glucoside (168.9 compared with 97.3 min) may have been related to the number of sugars contained in their structures: cyanidin 3-sambubioside contains one xylose and one glucose molecule, whereas cyanidin 3-glucoside contains only one glucose molecule. The mechanisms underlying the absorption of anthocyanins as glycosides are not clear. The results of one study suggest that quercetin glucosides can interact with the sodium-dependent glucose transport receptors in the mucosal epithelium (30). Quercetin and anthocyanidins (aglycones of anthocyanins) belong to the same flavonoid family and share a similar basic structure. Therefore, the detection of the anthocyanins in their unchanged glycated forms may indicate the involvement of the glucose transport receptors in the absorption of these compounds in vivo.
In this study, neither glucuronides nor sulfates of the anthocyanins were detected in the plasma or urine samples. It is possible that these anthocyanin conjugates were not extracted during the sample preparation nor detected by the diode array detector. Unfortunately, we did not use ß-D-glucuronidase and sulfatase digestion during the sample preparation.
In summary, for the first time, data were presented that describe the pharmacokinetics of dietary anthocyanins in humans. Anthocyanins were clearly absorbed in their unchanged glycated forms in humans.
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M.-C. Toufektsian, M. de Lorgeril, N. Nagy, P. Salen, M. B. Donati, L. Giordano, H.-P. Mock, S. Peterek, A. Matros, K. Petroni, et al. Chronic Dietary Intake of Plant-Derived Anthocyanins Protects the Rat Heart against Ischemia-Reperfusion Injury J. Nutr., April 1, 2008; 138(4): 747 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vitaglione, G. Donnarumma, A. Napolitano, F. Galvano, A. Gallo, L. Scalfi, and V. Fogliano Protocatechuic Acid Is the Major Human Metabolite of Cyanidin-Glucosides J. Nutr., September 1, 2007; 137(9): 2043 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Kay, G. Mazza, and B. J. Holub Anthocyanins Exist in the Circulation Primarily as Metabolites in Adult Men J. Nutr., November 1, 2005; 135(11): 2582 - 2588. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Stoner, C. Sardo, G. Apseloff, D. Mullet, W. Wargo, V. Pound, A. Singh, J. Sanders, R. Aziz, B. Casto, et al. Pharmacokinetics of Anthocyanins and Ellagic Acid in Healthy Volunteers Fed Freeze-Dried Black Raspberries Daily for 7 Days J. Clin. Pharmacol., October 1, 2005; 45(10): 1153 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, H. E. Pittman III, S. Mckay, and R. L. Prior Aglycones and Sugar Moieties Alter Anthocyanin Absorption and Metabolism after Berry Consumption in Weanling Pigs J. Nutr., October 1, 2005; 135(10): 2417 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Frank, M. Janssen, M. Netzel, G. Strass, A. Kler, E. Kriesl, and I. Bitsch Pharmacokinetics of Anthocyanidin-3-Glycosides Following Consumption of Hibiscus sabdariffa L. Extract J. Clin. Pharmacol., February 1, 2005; 45(2): 203 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halliwell, J. Rafter, and A. Jenner Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 268S - 276S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tesoriere, M. Allegra, D. Butera, and M. A Livrea Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: potential health effects of betalains in humans Am. J. Clinical Nutrition, October 1, 2004; 80(4): 941 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, H. E. Pittman III, and R. L. Prior Pelargonidin Is Absorbed and Metabolized Differently than Cyanidin after Marionberry Consumption in Pigs J. Nutr., October 1, 2004; 134(10): 2603 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dell'Agli, A. Busciala, and E. Bosisio Vascular effects of wine polyphenols Cardiovasc Res, September 1, 2004; 63(4): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Lazze, M. Savio, R. Pizzala, O. Cazzalini, P. Perucca, A. I. Scovassi, L. A. Stivala, and L. Bianchi Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines Carcinogenesis, August 1, 2004; 25(8): 1427 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Xu, K. Ikeda, and Y. Yamori Upregulation of Endothelial Nitric Oxide Synthase by Cyanidin-3-Glucoside, a Typical Anthocyanin Pigment Hypertension, August 1, 2004; 44(2): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Kroon, M. N Clifford, A. Crozier, A. J Day, J. L Donovan, C. Manach, and G. Williamson How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 15 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Talavera, C. Felgines, O. Texier, C. Besson, J.-L. Lamaison, and C. Remesy Anthocyanins Are Efficiently Absorbed from the Stomach in Anesthetized Rats J. Nutr., December 1, 2003; 133(12): 4178 - 4182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Prior Fruits and vegetables in the prevention of cellular oxidative damage Am. J. Clinical Nutrition, September 1, 2003; 78(3): 570S - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Felgines, S. Talavera, M.-P. Gonthier, O. Texier, A. Scalbert, J.-L. Lamaison, and C. Remesy Strawberry Anthocyanins Are Recovered in Urine as Glucuro- and Sulfoconjugates in Humans J. Nutr., May 1, 2003; 133(5): 1296 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell, N. M Brown, L. Zimmer-Nechemias, W. T Brashear, B. E Wolfe, A. S Kirschner, and J. E Heubi Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am. J. Clinical Nutrition, August 1, 2002; 76(2): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, G. Cao, and R. L. Prior Absorption and Metabolism of Anthocyanins in Elderly Women after Consumption of Elderberry or Blueberry J. Nutr., July 1, 2002; 132(7): 1865 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Felgines, O. Texier, C. Besson, D. Fraisse, J.-L. Lamaison, and C. Remesy Blackberry Anthocyanins Are Slightly Bioavailable in Rats J. Nutr., June 1, 2002; 132(6): 1249 - 1253. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |